Bewithus
ID Date Month Category Regulatory Update Details
1 26-02-2025 February Industry Specific CDSCO issues Circular regarding Gastro Resistant Tablets/Capsules, Delayed Release Tablets/Capsules as "New Drugs" as per Rule 2, (1)(w) of the New Drugs and Clinical Trials Rules, 2019-Reg CLICK HERE
2 26-02-2025 February Corporate BSE issues notice regarding Industry Standards on Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 CLICK HERE
3 26-02-2025 February Corporate NSE issues circular regarding SEBI Circular on the Industry Standards Note on Regulation 30 of the LODR Regulations CLICK HERE
4 26-02-2025 February Corporate NSE issues circular regarding Direct payout of securities to client demat account CLICK HERE
5 26-02-2025 February Corporate SEBI issues Circular for Industry Standards on Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 CLICK HERE
6 26-02-2025 February Corporate SEBI issues Circular for Opening of Demat Account in the name of Association of Persons CLICK HERE
7 26-02-2025 February Corporate RBI notifies Exposures of Scheduled Commercial Banks (SCBs) to Non-Banking Financial Companies (NBFCs) – Review of Risk Weights CLICK HERE
8 26-02-2025 February Corporate RBI notifies Review of Risk Weights on Microfinance Loans CLICK HERE
9 25-02-2025 February Industry Specific FSSAI issues order regarding Mandatory update of Form IX Nominee details by FBOs & auto-approval provision for Non-Form C modifications in FoSCoS-reg CLICK HERE
10 25-02-2025 February Industry Specific CDSCO issues notice regarding Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority -regarding CLICK HERE